Posted on: 09 February, 2022
The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leading technology, boosting our cancer and neuroscience research capabilities.
The Digital Spatial Profiling System has been made possible following a $535,000 grant from the Australian Research Council LIEF scheme. The project is being co-funded by the University of Sydney with a $250,000 contribution, .....
Read more
Category: Research Excellence, World-leading technology
Posted on: 08 February, 2022
Kolling researchers have taken out a highly-competitive, national award for an innovative program helping people get back to work after injury.
Professor Michael Nicholas and Dr Manasi Mittinty from the Pain Management Research Centre were part of a team which received a National Safety Award of Excellence for their initiative targeting injured workers.
The program was trialled with staff from Aust.....
Read more
Category: Awards, Research Excellence
Posted on: 20 December, 2021
Researchers have found that women are more likely to have a preterm birth when exposed to extreme heat and those with pre-existing conditions may have an even higher risk.
Preterm or premature birth, when a baby is born before 37 weeks of pregnancy, is the leading cause of infant death worldwide and many children born early deal with ongoing health problems for the remainder of their lives.
The tea.....
Read more
Category: Research Excellence
Posted on: 20 December, 2021
The largest study of its kind in Australia has found patients with a history of heart failure are three times more likely to die from COVID-19.
Launched last year at the outset of the pandemic, the AUS-COVID trial is investigating those who are most at risk from COVID-19 in Australia. To date, it has assessed hundreds of patients in 21 hospitals across the country.
The study confirmed earlier conce.....
Read more
Category: Cardiovascular and Renal Research, Research Excellence
Posted on: 06 December, 2021
Research conducted by a team from Kolling Institute has found that swallowing difficulties after a whiplash injury appear to be an under-recognised consequence of the injury.
The study investigated a group of 60 patients with low-grade whiplash, finding 50 per cent of patients reported swallowing problems within 12 months of their whiplash injury.
In 31 of these patients, there was a statistically .....
Read more
Category: Musculoskeletal Research, Research Excellence
Posted on: 26 November, 2021
In what will be disappointing news for many, a large-scale clinical trial has found platelet-rich plasma injections for those with osteoarthritis knee pain are no better than a placebo.
This type of injection has become an increasingly popular form of treatment for knee joint arthritis, despite its prohibitive cost at around $2,000 per injection.
Plasma from a patient’s own blood is injected direct.....
Read more
Category: Research Excellence
Posted on: 22 November, 2021
The Kolling’s new research plan has been confirmed marking an important milestone for the institute.
The plan details the implementation of the institute’s five-year strategy, and will ensure the Kolling is in the best position to deliver game-changing research.
Acting Executive Director Professor Jim Elliott has welcomed the development of the plan, saying a robust strategic framework will help sh.....
Read more
Category: Research Excellence
Posted on: 17 November, 2021
The Kolling Institute’s Executive Director Professor Carolyn Sue will join a dynamic group of Australian leaders on the new National Health and Medical Research Council.
Professor Sue has been appointed to the high profile body for a three-year term until June 2024. A record number of women are represented on the new council, including chair and internationally-renowned researcher Professor Carolin.....
Read more
Category: Research Excellence
Posted on: 16 November, 2021
A team from the Kolling Institute led by Professor Sarah Hilmer has helped develop a valuable, new national program to reduce the adverse impacts of taking multiple medicines.
Medicines with an anticholinergic effect can successfully treat many conditions such as depression, dementia and chronic non-cancer pain.
Cumulatively however, they can cause serious adverse effects such as falls, confusion, .....
Read more
Category: New Treatment, Research Excellence
Posted on: 09 November, 2021
An important new partnership has been formed to dramatically improve care for musculoskeletal conditions by speeding up the translation of research to clinical practice.
The Northern Sydney Local Health District has joined with the University of Sydney and Sydney Local Health District to create Sydney Musculoskeletal Health which will link researchers from across the University with clinicians, con.....
Read more
Category: Musculoskeletal Research, New Treatment, Research Excellence